Dr. EVO
ActiveSummary
Dr. EVO has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €451,382 and a net result of €157,431. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 82% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
23-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
03-04
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Equity above €200,000equity €293,952 ▲77.4%
A profit in every financial year since 2023 builds equity to €293,952.
15-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.